Financial Performance - Hess Midstream LP reported fourth-quarter 2025 earnings per share of $0.72, meeting analyst expectations, while revenue was $404.2 million, falling short of the forecast of $417.05 million [1] - The net income for the quarter totaled $168.0 million, with $93.3 million attributable to Hess Midstream LP [2] - Adjusted EBITDA reached $309.1 million, and adjusted free cash flow totaled $207.8 million, indicating resilient financial performance despite lower throughput volumes [2] Operational Metrics - Throughput volumes declined year over year across all segments: oil terminaling volumes decreased by 4%, gas processing by 1%, and water gathering by 5% [3] - The declines in throughput were primarily attributed to reduced production caused by severe winter weather [3] - Capital expenditures for the quarter totaled $47.6 million, down 44% from the prior-year period, reflecting the completion of gas compression expansion projects [3]

Core Viewpoint - Abbott Laboratories' shares fell over 9% intra-day following fourth-quarter earnings that met expectations but missed revenue targets, along with weaker guidance for the first quarter [1] Financial Performance - Adjusted earnings per share for the quarter were $1.50, aligning with analyst estimates [2] - Revenue totaled $11.46 billion, below the consensus forecast of $11.8 billion, with total sales increasing by 4.4% on a reported basis and 3.0% organically [2] - Organic growth, excluding COVID-19 testing-related sales, was 3.8% compared to the prior-year quarter [2] Segment Performance - The Medical Devices segment showed strong results, with revenue increasing by 12.3% to $5.68 billion [3] - Diabetes Care sales, including continuous glucose monitoring products, rose by 14.5% to $2.13 billion [3] - Nutrition revenue declined by 8.9% to $1.94 billion due to lower volumes and strategic pricing actions [3] - Diagnostics revenue fell by 2.5% to $2.46 billion, attributed to reduced demand for COVID-19 testing [3] Future Guidance - For the first quarter of 2026, Abbott projected adjusted earnings per share of $1.12 to $1.18, below the analyst consensus of $1.20 [2] - For the full year 2026, Abbott forecasted organic sales growth of 6.5% to 7.5% and adjusted earnings per share of $5.55 to $5.80, exceeding the analyst consensus of $5.17 and representing approximately 10% growth at the midpoint [4]

Core Viewpoint - Royal Caribbean's stock is expected to decline due to another revenue miss, despite a profit beat and increasing demand for cruises [1] Revenue Performance - The company reported a revenue miss, which overshadowed the positive profit results [1] Profitability - Royal Caribbean achieved a profit beat, indicating strong operational performance [1] Demand Trends - There is an accelerating demand for cruises, suggesting a positive outlook for the industry despite the revenue miss [1]

Core Insights - Hims & Hers Health reported a 73% increase in revenue for the second quarter, reaching $544.8 million compared to $315.6 million in the same period last year [1] - The company experienced a net income of $42.5 million, or 17 cents per share, up from $13.3 million, or 6 cents per share, year-over-year [1] - Despite strong year-over-year growth, the company's second-quarter results fell short of Wall Street's revenue expectations, leading to a 9% decline in shares during extended trading [1] Revenue Expectations - For the third quarter, Hims & Hers anticipates revenue between $570 million to $590 million, slightly below analysts' expectations of $583 million [2] - The adjusted EBITDA for the upcoming quarter is projected to be between $60 million to $70 million, while analysts had expected $77.1 million [2] Earnings Comparison - The adjusted earnings per share for the second quarter were reported at 17 cents, compared to an expectation of 15 cents [3] - Revenue for the second quarter was reported at $544.8 million, which was slightly below the expected $552 million [3]

Group 1 - The core viewpoint is that Spotify's shares fell approximately 4% after the company reported weaker-than-expected financial results and guidance for the upcoming quarter [1][2] - Spotify's revenues increased by 10% year-over-year, reaching about 3.81 billion euros in the previous year [1] - The company reported a net loss of 86 million euros, translating to a loss of 0.42 euros per share, a significant decline from a net income of 225 million euros or 1.10 euros per share in the same quarter last year [1] Group 2 - The third-quarter revenue guidance is below Wall Street's expectations, with Spotify projecting revenues of 4.2 billion euros compared to the 4.47 billion euros forecasted by analysts [2] - The forecast includes a 490-basis-point headwind attributed to foreign exchange rates [2] - Actual revenue for the last quarter was 4.19 billion euros, which also fell short of the expected 4.26 billion euros [3]

Core Insights - Expedia Group Inc reported first-quarter revenue of $2.99 billion, a 3% increase year-over-year, but fell short of the consensus estimate of $3.01 billion [1] - The revenue growth was driven by B2B and Advertising segments, which increased by 14% and 20% year-over-year, respectively [1] - The company reported earnings per share of 40 cents, exceeding the consensus estimate of 29 cents per share [2] - Booked room nights rose by 6% year-over-year, despite softened travel demand in the U.S., while lodging gross bookings increased by 5% [2] - Total gross bookings were up 4% year-over-year in the first quarter [2] - CEO Ariane Gorin stated that the company achieved bookings and revenue within guidance despite weaker demand, and anticipates margin expansion and revenue growth in the future [3] Stock Performance - Expedia's stock declined by 6.88% to $157.36 in after-hours trading, with a 52-week trading range of $107.25 to $207.73 [4]